IL50390A0 - Novel sulphemoyl derivatives their production and pharmaceutical compositions containing them - Google Patents
Novel sulphemoyl derivatives their production and pharmaceutical compositions containing themInfo
- Publication number
- IL50390A0 IL50390A0 IL50390A IL5039076A IL50390A0 IL 50390 A0 IL50390 A0 IL 50390A0 IL 50390 A IL50390 A IL 50390A IL 5039076 A IL5039076 A IL 5039076A IL 50390 A0 IL50390 A0 IL 50390A0
- Authority
- IL
- Israel
- Prior art keywords
- sulphemoyl
- derivatives
- novel
- production
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1136675 | 1975-09-02 | ||
| CH1136775 | 1975-09-02 | ||
| CH1419475 | 1975-11-04 | ||
| CH21876 | 1976-01-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL50390A0 true IL50390A0 (en) | 1976-10-31 |
Family
ID=27427797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL50390A IL50390A0 (en) | 1975-09-02 | 1976-08-31 | Novel sulphemoyl derivatives their production and pharmaceutical compositions containing them |
Country Status (11)
-
1976
- 1976-08-23 DE DE19762637882 patent/DE2637882A1/de active Pending
- 1976-08-24 FI FI762419A patent/FI762419A/fi not_active Application Discontinuation
- 1976-08-24 DK DK380176A patent/DK380176A/da unknown
- 1976-08-25 NO NO762922A patent/NO762922L/no unknown
- 1976-08-26 SE SE7609494A patent/SE7609494L/xx unknown
- 1976-08-31 ES ES451113A patent/ES451113A1/es not_active Expired
- 1976-08-31 PT PT65538A patent/PT65538B/pt unknown
- 1976-08-31 IL IL50390A patent/IL50390A0/xx unknown
- 1976-09-01 AU AU17373/76A patent/AU1737376A/en not_active Expired
- 1976-09-01 JP JP51103766A patent/JPS5233645A/ja active Pending
- 1976-09-02 FR FR7626461A patent/FR2322592A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2322592B1 (US20100268047A1-20101021-C00003.png) | 1978-11-17 |
| FI762419A (US20100268047A1-20101021-C00003.png) | 1977-03-03 |
| ES451113A1 (es) | 1977-11-16 |
| NO762922L (US20100268047A1-20101021-C00003.png) | 1977-03-03 |
| SE7609494L (sv) | 1977-03-03 |
| DK380176A (da) | 1977-03-03 |
| AU1737376A (en) | 1978-03-09 |
| FR2322592A1 (fr) | 1977-04-01 |
| JPS5233645A (en) | 1977-03-14 |
| PT65538B (fr) | 1978-05-10 |
| DE2637882A1 (de) | 1977-03-03 |
| PT65538A (fr) | 1976-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL50836A0 (en) | Novel cyclopolypeptides their production and pharmaceutical compositions containing them | |
| IL51076A0 (en) | New glucosamine derivatives their manufacture and pharmaceutical compositions containing them | |
| IL53533A0 (en) | Novel tetralin derivatives their production and pharmaceutical compositions containing them | |
| IL49022A0 (en) | Isoxazolylbenzamide derivatives,their production and pharmaceutical compositions containing them | |
| IL51133A0 (en) | New ergoline derivatives their production and pharmaceutical compositions containing them | |
| IL51087A0 (en) | New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them | |
| GB1537880A (en) | 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them | |
| IL50091A (en) | 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them | |
| JPS527999A (en) | Production of evrnamenine derivatives and pharmaceutical composition | |
| IL51426A0 (en) | Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them | |
| IL53332A0 (en) | Morphanthridine derivatives their production and pharmaceutical compositions containing them | |
| IL50542A0 (en) | Novel substituted pyridinecarboxamides their manufacture and pharmaceutical compositions containing them | |
| IL51334A0 (en) | Novel pyrrolidine derivatives their production and pharmaceutical compositions containing them | |
| IL50263A0 (en) | New indole derivatives their production and pharmaceutical compositions containing them | |
| IL49862A0 (en) | New benzocycloheptathiophene derivatives,their production and pharmaceutical compositions containing them | |
| IL50298A0 (en) | Novel cephem derivatives their manufacture and pharmaceutical compositions containing them | |
| IL48054A (en) | 14-deoxy-14-substituted vincanol derivatives their production and pharmaceutical compositions containing them | |
| JPS525799A (en) | Production of indroquinolidine derivative and pharmaceutical composition containing same | |
| IL48713A0 (en) | Novel ferrocene derivatives,their production and pharmaceutical compositions containing them | |
| IL53013A0 (en) | 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them | |
| IL49785A0 (en) | Benzocycloheptathiophene derivatives,their production and pharmaceutical compositions containing them | |
| IL50531A0 (en) | New dibenzodiazepines their production and pharmaceutical compositions containing them | |
| IL50198A0 (en) | New morphanthridine derivatives their production and pharmaceutical compositions containing them | |
| IL51016A0 (en) | Novel acetamides their production and pharmaceutical compositions containing them | |
| IL51104A0 (en) | Novel isoquinoline derivatives their production and pharmaceutical compositions containing them |